What is Human API?
Human API operates a sophisticated digital health data platform designed to connect, normalize, and structure information from a vast network of hospitals, pharmacies, laboratories, and wearable devices. By providing a unified API layer, the company enables organizations to access electronic health records (EHR) and personal device data, thereby facilitating the development of consumer-centric health services. This infrastructure is essential for modernizing health delivery, as it allows for the seamless flow of information that is traditionally siloed within legacy healthcare systems. Through its commitment to data privacy and consumer trust, Human API has established itself as a foundational utility for the next generation of digital therapeutics and personalized medicine.
How much funding has Human API raised?
Human API has raised a total of $37M across 5 funding rounds:
Debt
$75K
Series A
$6.6M
Series B
$10M
Debt
$350K
Series C
$20M
Debt (2013): $75K with participation from Undisclosed
Series A (2015): $6.6M, investors not publicly disclosed
Series B (2019): $10M supported by Guardian Healthcare and Healthcare Ventures
Debt (2020): $350K featuring PPP
Series C (2020): $20M backed by Allianz Life Insurance Company of North America, CNO Financial Group, Inc., Samsung NEXT company, and Moneta VC
Key Investors in Human API
Allianz Life Insurance Company of North America
A prominent financial services provider with a long history of offering life insurance and annuity products, focusing on long-term stability and strategic investments in the insurance technology sector.
Guardian Healthcare
A healthcare services organization dedicated to providing high-quality home care and patient support, with a strategic interest in technologies that improve patient data accessibility.
Healthcare Ventures
A specialized life science venture capital firm that focuses on early-stage companies with the potential to transform patient care through innovative medical and digital solutions.
What's next for Human API?
With the successful completion of its latest capital raise, Human API is well-positioned to accelerate its market expansion and deepen its integration capabilities. The strategic focus will likely shift toward enhancing the platform's data normalization engine and expanding its reach into new segments of the healthcare value chain, such as advanced clinical research and predictive health analytics. As the industry moves toward a more integrated, patient-centered model, Human API's ability to provide high-fidelity, real-time data will be a key differentiator. The company is expected to leverage this recent investment to strengthen its enterprise partnerships and continue its mission of democratizing access to health information, ultimately driving greater efficiency and improved outcomes across the global healthcare landscape.
See full Human API company page
